Australia markets closed

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0300-0.0700 (-6.36%)
At close: 04:00PM EDT
1.0400 +0.01 (+0.97%)
Pre-market: 06:30AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 198.52M
Enterprise value 327.94M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.81
Price/book (mrq)0.89
Enterprise value/revenue 15.09
Enterprise value/EBITDA -2.49

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3-69.35%
S&P500 52-week change 321.83%
52-week high 35.5300
52-week low 30.8800
50-day moving average 31.2592
200-day moving average 32.5549

Share statistics

Avg vol (3-month) 38.7M
Avg vol (10-day) 34.39M
Shares outstanding 5192.74M
Implied shares outstanding 6207.68M
Float 8108.82M
% held by insiders 10.38%
% held by institutions 165.11%
Shares short (28 Mar 2024) 429.75M
Short ratio (28 Mar 2024) 42.99
Short % of float (28 Mar 2024) 416.48%
Short % of shares outstanding (28 Mar 2024) 415.43%
Shares short (prior month 29 Feb 2024) 434.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21544:1000
Last split date 305 Nov 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-683.74%

Management effectiveness

Return on assets (ttm)-15.01%
Return on equity (ttm)-47.81%

Income statement

Revenue (ttm)21.73M
Revenue per share (ttm)0.21
Quarterly revenue growth (yoy)17,353.50%
Gross profit (ttm)N/A
EBITDA -131.77M
Net income avi to common (ttm)-91.17M
Diluted EPS (ttm)-0.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)174.29M
Total cash per share (mrq)1.59
Total debt (mrq)303.71M
Total debt/equity (mrq)136.48%
Current ratio (mrq)1.55
Book value per share (mrq)2.08

Cash flow statement

Operating cash flow (ttm)-277.48M
Levered free cash flow (ttm)-116.62M